Clinical Research

Is IVL safe for patients with diabetes?
New two-year data confirm that the IVL technology developed by Shockwave Medical can be used to treat diabetic patients who require PCI.
M-TEER still beneficial for high-risk patients with smaller mitral valve areas
Mitral valve surgery can be especially challenging when patients present with a small mitral valve area. When it comes to M-TEER, however, treatment still appears to be both safe and effective.
Researchers receive $3.2M in federal funding to test new heart pump for children
The device, currently just a prototype, could be the first of its kind to gain FDA approval.
Neuralink users reveal power to move robotic arms, play video games with their minds
The results were shown in multiple posts on X. A clinical trial to prove the safety and efficacy of Elon Musk's brain implant is ongoing, with 12 people currently using the devices.
Adjustable interatrial shunt for heart failure shows promise in first-in-human trial
Gregg Stone, MD, spoke to Cardiovascular Business about early data from the ATHENS-HF trial. Ten heart failure patients were treated with the adjustable device, and each implant was a success.

Texas researchers receive $1.14M to develop first CVD drug of its kind

If successful, the group's first-in-class medication would be able to target inflammation in CVD patients before it even occurs.

cardiologist doctor physician patient black diverse hypertension

Weight loss drug semaglutide linked to multiple benefits for heart failure patients

Researchers think their findings, which were presented at ESC Congress 2023 and published in the New England Journal of Medicine, could "change the nature of the conversation about the role of obesity in HFpEF."

A complete list of the European Society of Cardiology (ESC) 2023 Congress late-breaking Hot Line sessions. #ESCCongress

ESC Congress 2023 to feature 30 late-breaking clinical trials

The European Society of Cardiology's annual meeting is scheduled for Aug. 25-28, 2023, in Amsterdam.

Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Serious discrepancies between preliminary imaging reads and final radiology reports are at risk of accumulating when the prelims are rendered during overnight hours.

semaglutide wegovy Novo Nordisk major adverse cardiovascular events

Weight loss drug semaglutide reduces risk of adverse cardiovascular events by 20% among overweight, obese patients

Weekly subcutaneous treatments of semaglutide, originally developed to treat diabetes, are sold and marketed under the brand name Wegovy.

Colchicine before PCI: New research tracks the long-term impact on heart health

Researchers shared long-term follow-up data from the Colchicine-PCI trial, which compared colchicine administration before PCI with a placebo.

New research on AI-based CCTA assessments wins Best Abstract at SCCT 2023

Out of more than 250 abstracts submitted at its annual meeting in Boston, SCCT named one winner and two runners-up.

Peter Libby, MD, explains how infections cause heart attacks. This came out of research taking a close look at COVID, but the inflammation from any infection may cause increased inflammation of coronary plaques that cause heart attacks. #COVID #COVID19

Do infections cause heart attacks? Lessons from COVID

COVID-19 opened the eyes of many cardiology researchers that infections may promote inflammation in atherosclerotic plaques, leading to cardiac events.

Clinical Research

Is IVL safe for patients with diabetes?

M-TEER still beneficial for high-risk patients with smaller mitral valve areas

Researchers receive $3.2M in federal funding to test new heart pump for children

Neuralink users reveal power to move robotic arms, play video games with their minds

Adjustable interatrial shunt for heart failure shows promise in first-in-human trial